Biotech

Shares of companies developing stem cell therapies surged Wednesday on news that the federal government has cleared 13 new stem cell lines for testing, bringing to a close nearly a decade of restrictions. The news from the National Institutes of Health should provide some relief to...

The new Certificate in Stem Cell Techniques launched this fall at Madison Area Technical College (MATC) provides advanced-degree training in practical laboratory courses. It is thought to be the first course of its kind offered by a traditional two-year college. “This really makes sense in...

The FBI recently approved the Promega PowerPlex® 16 HS System for use by laboratories participating in, or generating DNA records for, the National DNA Index System (NDIS). NDIS currently contains more than seven million profiles and has assisted in over 94,000 investigations. It is populated...

The NY Times reported today on how the concept of shared; low cost supercomputers are being paired with high performance computers from companies with strong Wisconsin Roots including as Cray and Silicon Graphics. The story revealed how users and developers of supercomputer users are using...

The first half of 2009 showed the tough road biotech, and other industries, had to hoe in order to survive. Earlier forecast this year were that many biotech companies would fail, go under, be delisted from the different exchanges, or barely hang on. But like...

Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair. The study included 35 patients who received CD 133+...